Prosight Management, LP Kura Oncology, Inc. Transaction History

Prosight Management, LP

$378 Million
Q3 2025

A detailed history of Prosight Management, LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Prosight Management, LP holds 2,758,516 shares of KURA stock, worth $30.9 Million. This represents 6.45% of its overall portfolio holdings.

Number of Shares

2,758,516

Previous 3,181,184 13.29%

Holding current value

$30.9 Million

Previous $18.4 Million 33.0%

% of portfolio

6.45%

Previous 4.97%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$5.54 - $9.05 $2.34 Million - $3.83 Million	-422,668 Reduced 13.29%	2,758,516 $24.4 Million
Q2 2025 Aug 14, 2025	BUY	$5.55 - $6.92 $6.12 Million - $7.63 Million	1,102,869 Added 53.07%	3,181,184 $18.4 Million
Q1 2025 May 15, 2025	BUY	$6.6 - $9.05 $4.97 Million - $6.82 Million	753,315 Added 56.85%	2,078,315 $13.7 Million
Q4 2024 Feb 14, 2025	BUY	$8.51 - $19.21 $5.28 Million - $11.9 Million	619,891 Added 87.91%	1,325,000 $11.5 Million
Q3 2024 Nov 14, 2024	BUY	$18.57 - $23.23 $1.4 Million - $1.75 Million	75,209 Added 11.94%	705,109 $13.8 Million

Q2 2024 Aug 14, 2024	SELL	$17.53 - $22.98 $5.79 Million - $7.59 Million	-330,100 Reduced 34.39%	629,900 $13 Million
Q1 2024 May 15, 2024	BUY	$13.42 - $23.53 $134,200 - $235,300	10,000 Added 1.05%	960,000 $20.5 Million
Q4 2023 Feb 14, 2024	SELL	$7.58 - $14.38 $7.45 Million - $14.1 Million	-982,456 Reduced 50.84%	950,000 $13.7 Million
Q3 2023 Nov 14, 2023	BUY	$8.44 - $11.86 $4.97 Million - $6.99 Million	589,097 Added 43.85%	1,932,456 $17.6 Million
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $12.9 Million - $18.8 Million	1,343,359 New	1,343,359 $14.2 Million
Q4 2020 Feb 12, 2021	SELL	$29.0 - $41.62 $3.11 Million - $4.47 Million	-107,367 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$16.3 - $30.64 $9.42 Million - $17.7 Million	-577,633 Reduced 84.33%	107,367 $3.29 Million
Q2 2020 Aug 14, 2020	SELL	$7.95 - $18.81 $6.08 Million - $14.4 Million	-765,000 Reduced 52.76%	685,000 $11.2 Million
Q1 2020 May 15, 2020	BUY	$6.45 - $14.04 $2.67 Million - $5.81 Million	414,000 Added 39.96%	1,450,000 $14.4 Million
Q4 2019 Feb 14, 2020	BUY	$12.97 - $15.94 $1.92 Million - $2.36 Million	147,848 Added 16.65%	1,036,000 $14.2 Million
Q3 2019 Nov 14, 2019	BUY	$14.75 - $20.87 $300,044 - $424,537	20,342 Added 2.34%	888,152 $13.5 Million
Q2 2019 Aug 14, 2019	BUY	$14.71 - $19.79 $10.2 Million - $13.8 Million	694,916 Added 401.93%	867,810 $17.1 Million
Q1 2019 May 15, 2019	SELL	$13.73 - $16.87 $1.97 Million - $2.42 Million	-143,687 Reduced 45.39%	172,894 $2.87 Million
Q4 2018 Feb 14, 2019	BUY	$10.6 - $17.49 $667,270 - $1.1 Million	62,950 Added 24.82%	316,581 $4.45 Million
Q3 2018 Nov 15, 2018	SELL	$16.65 - $21.85 $570,362 - $748,493	-34,256 Reduced 11.9%	253,631 $4.44 Million
Q2 2018 Aug 14, 2018	BUY	$14.8 - $18.8 $4.26 Million - $5.41 Million	287,887 New	287,887 $5.24 Million

Others Institutions Holding KURA

# of Institutions

214

Shares Held

81.2M

Call Options Held

900K

Put Options Held

228K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $749M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.

Account

Prosight Management, LP Kura Oncology, Inc. Transaction History